ARCT
Arcturus Therapeutics Holdings Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $21.03
- Day High
- $21.42
- Day Low
- $20.27
- Day Open
- $21.42
- Volume
- 8950
- Day Change
- -1%
Latest news data for ARCT
Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis
marketscreener.com
CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
prnewswire.com
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
marketwatch.com
Why CSL Ltd Stock Could Be Worth a Look
entrepreneur.com
Why did the CSL share price leap 7% in November?
fool.com.au
Arcturus Theraputics Should Benefit From A Variety Of Positive Developments (NASDAQ:ARCT)
seekingalpha.com
Markets Settle Into Retail Earnings: Analysts Upgrade or Downgrade Bank of America, Nio and More – 24
247wallst.com
Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2022 Earnings Call Transcript
seekingalpha.com
Arcturus Therapeutics to Present at the Following Investor Conferences in November
startup365.fr
Friday’s Top Analysts Upgrades and Downgrades: AMD, Bilibili, Cognizant, Dynatrace, Equinix, Match, Nutrien, Robinhood, Roku and More – 24
247wallst.com